The National Institutes of Health (NIH) funds and supports a wide range of clinical trials, including those focused on cancer. These trials are meticulously designed to assess new treatments, drugs, or interventions that could potentially improve the outcomes for cancer patients. NIH-supported clinical trials are crucial in the advancement of oncology research and in the development of new standards of care.